# Clinical pharmacists and drug-related problem management in a South African hospital

**Authors:** Mukonazwothe J. Luvhimbi, Phumzile Skosana, Nkhensani Shirindza, Elmien Bronkhorst

PMC · DOI: 10.4102/hsag.v31i0.3337 · Health SA Gesondheid · 2026-02-26

## TL;DR

This study shows that clinical pharmacists in a South African hospital help reduce drug-related problems, especially missed doses and duplicate therapies.

## Contribution

The study demonstrates the effectiveness of clinical pharmacists in identifying and resolving drug-related problems in a South African hospital setting.

## Key findings

- 241 drug-related problems were identified across 181 patients, averaging 1.76 DRPs per patient.
- Failure to receive therapy (53.1%) was the most common DRP, often due to omitted doses.
- Clinical pharmacist recommendations were accepted by 37.2% of nurses and 22.7% of doctors.

## Abstract

Drug-related problems (DRPs) negatively impact health outcomes and are more likely in patients with multiple comorbidities and polypharmacy. Involving clinical pharmacists in multidisciplinary teams can improve drug safety and efficacy by preventing DRPs.

This study aimed to identify and analyse DRPs and highlight the role of clinical pharmacists in minimising DRPs.

This study was conducted in the internal medicine wards of a tertiary hospital in South Africa.

A descriptive quantitative study was conducted using purposive sampling, including all inpatients in internal medicine wards. Drug-related problems were identified through daily reviews of patient files using a standardised pharmaceutical care form. Findings were communicated to the healthcare team. Data were analysed descriptively using Stata.

A total of 181 patient cases were reviewed, with most patients being male (65.2%) and aged 20–40 years (35.9%). A total of 241 DRPs were recorded, averaging 1.76 DRPs per patient. The most frequent DRP was failure to receive therapy (53.1%), often because of omitted doses. The clinical pharmacist made 277 recommendations, with 37.2% accepted by nurses and 22.7% by doctors.

Clinical pharmacists effectively identified and addressed DRPs, particularly omitted doses and therapeutic duplication. The integration of clinical pharmacists into healthcare teams can significantly reduce DRPs and enhance patient safety.

This study raises awareness of drug-related problems and supports the development of strategies to prevent them in hospitalised patients.

## Full-text entities

- **Diseases:** DRPs (MESH:D000081015), overdose (MESH:D062787), cognitive impairment (MESH:D003072), HIV/AIDS (MESH:D015658), hypertension (MESH:D006973), death (MESH:D003643), toxicity (MESH:D064420), vomiting (MESH:D014839), metabolic problems (MESH:D008659), pain (MESH:D010146), diabetes (MESH:D003920)
- **Chemicals:** Paracetamol (MESH:D000082)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12969568/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12969568/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC12969568/full.md

---
Source: https://tomesphere.com/paper/PMC12969568